Listed

Lantheus Holdings, Inc.

LNTHNasdaqCIK 1521036HealthcareFiscal year ends Dec 31

Reports and events: 228 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Lantheus Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2019-03-2509:20 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-084409
2019-03-1507:30 ETDEF 14AProxy statementPeriod 2019-04-240001193125-19-075696
2019-02-2009:07 ET10-KAnnual reportPeriod 2018-12-310001628280-19-001574
2019-02-1916:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-19-001540
2019-01-2816:10 ET8-K5.02 Departure or appointment of officers or directors0001193125-19-018868
2018-10-3017:16 ET10-QQuarterly reportPeriod 2018-09-300001628280-18-013111
2018-10-3016:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-013080
2018-09-2116:36 ET8-K5.02 Departure or appointment of officers or directors0001193125-18-280057
2018-09-2116:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-18-280049
2018-08-2016:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-252911
2018-08-0117:15 ET10-QQuarterly reportPeriod 2018-06-300001628280-18-010222
2018-08-0116:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-010191
2018-07-2611:10 ET8-K5.02 Departure or appointment of officers or directors0001193125-18-227207
2018-06-0617:29 ET8-K8.01 Other events0001193125-18-185806
2018-05-0217:09 ET10-QQuarterly reportPeriod 2018-03-310001628280-18-005734
2018-05-0216:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-005685
2018-04-2716:30 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-18-139044
2018-03-1607:40 ETDEF 14AProxy statementPeriod 2018-04-260001193125-18-084812
2018-02-2709:20 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-059615
2018-02-2617:12 ET10-KAnnual reportPeriod 2017-12-310001628280-18-002261
2018-02-2616:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-18-002223
2018-01-0516:05 ET8-K1.01 Entry into a material agreement; 8.01 Other events0001193125-18-004432
2017-11-0217:07 ET10-QQuarterly reportPeriod 2017-09-300001628280-17-010720
2017-11-0216:03 ET8-K9.01 Financial statements and exhibits0001628280-17-010670
2017-09-0717:02 ET8-K5.02 Departure or appointment of officers or directors0001193125-17-279371
2017-08-1416:11 ET8-K8.01 Other events0001193125-17-257257
2017-08-0117:18 ET10-QQuarterly reportPeriod 2017-06-300001193125-17-244385
2017-08-0116:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-244254
2017-06-1617:17 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-206121
2017-05-0517:15 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-161014
2017-05-0217:14 ET10-QQuarterly reportPeriod 2017-03-310001193125-17-154209
2017-05-0216:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-153944
2017-04-2816:16 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-17-148200
2017-04-2508:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-135688
2017-03-3016:05 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-104040
2017-03-1706:10 ETDEF 14AProxy statementPeriod 2017-04-270001193125-17-086152
2017-03-1517:20 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-083842
2017-02-2316:05 ET10-KAnnual reportPeriod 2016-12-310001193125-17-053986
2017-02-2116:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-050380
2017-02-2116:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-050369
2017-01-2608:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-17-018871
2016-11-1716:53 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-771018
2016-11-0117:18 ET10-QQuarterly reportPeriod 2016-09-300001193125-16-755496
2016-11-0116:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-755296
2016-09-1316:14 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-708511
2016-09-0216:51 ET8-K1.01 Entry into a material agreement0001193125-16-700932
2016-08-2516:45 ET10-Q/AQuarterly report, amendedPeriod 2016-03-310001193125-16-691781
2016-08-1117:18 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001193125-16-679420
2016-08-0417:20 ET10-QQuarterly reportPeriod 2016-06-300001193125-16-672020
2016-08-0416:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-671766

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.